Dermatology report document

- DERMTECH, INC.
Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description

The sole FIGURE is a front view of a dermatology report document, showing our new design.

The peripheral broken lines represent an unclaimed boundary of the dermatology report document and form no part of the claimed design. Within the peripheral broken lines, the broken line showing of text and other features of the dermatology report document is for environmental purposes only and forms no part of the claimed design. The difference in crosshatch shading indicates a contrast of appearance and does not depict any particular color, texture, or material.

The dermatology report document has no appreciable thickness.

Claims

The ornamental design for a dermatology report document, as shown and described.

Referenced Cited
U.S. Patent Documents
4122947 October 31, 1978 Falla
5190049 March 2, 1993 Briggs et al.
5921396 July 13, 1999 Brown, Jr.
D424541 May 9, 2000 Mugura
D430120 August 29, 2000 Yasui et al.
6106732 August 22, 2000 Johnston et al.
6176836 January 23, 2001 Trudil et al.
6447463 September 10, 2002 Borkowski
6720145 April 13, 2004 Rheins et al.
D504440 April 26, 2005 Luquet
6949338 September 27, 2005 Rheins et al.
7183057 February 27, 2007 Benson
7297480 November 20, 2007 Vogt
D570857 June 10, 2008 Nguyen et al.
7921999 April 12, 2011 Kimball
7989165 August 2, 2011 Benson
D673166 December 25, 2012 Mori et al.
8541170 September 24, 2013 Kennedy et al.
8938684 January 20, 2015 Guertler et al.
9057109 June 16, 2015 Chang
D764580 August 23, 2016 Solomon
D764581 August 23, 2016 Solomon
D786282 May 9, 2017 Donnelly
D788142 May 30, 2017 Burke
D816697 May 1, 2018 Ledford et al.
D816699 May 1, 2018 Ledford et al.
D816700 May 1, 2018 Bayer et al.
D824402 July 31, 2018 Donnelly
D847840 May 7, 2019 Poschel et al.
10407729 September 10, 2019 Chang
D865056 October 29, 2019 Martin
D874474 February 4, 2020 Rognlie et al.
10709428 July 14, 2020 Palmer et al.
D900130 October 27, 2020 Matos et al.
D930010 September 7, 2021 Caudill et al.
D944284 February 22, 2022 Metzger et al.
D944286 February 22, 2022 Sanchez et al.
D946017 March 15, 2022 Courtney et al.
11307876 April 19, 2022 Leonard et al.
20020110824 August 15, 2002 Rheins et al.
20020115086 August 22, 2002 Rheins et al.
20020119471 August 29, 2002 Rheins et al.
20020127573 September 12, 2002 Rheins et al.
20020150918 October 17, 2002 Rheins et al.
20030045810 March 6, 2003 Borkowski
20030098580 May 29, 2003 Christy
20060242554 October 26, 2006 Gerace et al.
20070087323 April 19, 2007 Armitage et al.
20070243537 October 18, 2007 Tuck et al.
20070281314 December 6, 2007 Benson
20080138819 June 12, 2008 Vogt
20080200870 August 21, 2008 Palmroos et al.
20080274908 November 6, 2008 Chang
20100086501 April 8, 2010 Chang et al.
20100105102 April 29, 2010 Hanes et al.
20100279877 November 4, 2010 Vogt
20110160080 June 30, 2011 Chang
20120065086 March 15, 2012 Benson
20130296185 November 7, 2013 Benson
20140154684 June 5, 2014 Chang
20140323331 October 30, 2014 Chang et al.
20150005184 January 1, 2015 Alsobrook et al.
20150259739 September 17, 2015 Chang et al.
20150361500 December 17, 2015 Ang et al.
20160024595 January 28, 2016 Alsobrook, II
20190367994 December 5, 2019 Chang
20200149115 May 14, 2020 Dobak et al.
20200289099 September 17, 2020 Palmer et al.
20200308649 October 1, 2020 Dobak et al.
20200308657 October 1, 2020 Dobak et al.
20200319205 October 8, 2020 Dobak et al.
20200383665 December 10, 2020 Palmer et al.
20200407800 December 31, 2020 Dobak et al.
20210196247 July 1, 2021 Palmer et al.
20210198749 July 1, 2021 Chang
20210222246 July 22, 2021 Dobak et al.
20210222247 July 22, 2021 Dobak et al.
20210222258 July 22, 2021 Chang
20210246514 August 12, 2021 Chang
Foreign Patent Documents
WO-0010579 March 2000 WO
WO-03001985 January 2003 WO
WO-2005100603 October 2005 WO
WO-2007124072 November 2007 WO
WO-2008137772 November 2008 WO
WO-2009140550 November 2009 WO
WO-2010025341 March 2010 WO
WO-2010097773 September 2010 WO
WO-2014176446 October 2014 WO
WO-2014210467 December 2014 WO
WO-2016014705 January 2016 WO
WO-2016179043 November 2016 WO
WO-2017165199 September 2017 WO
WO-2018191268 October 2018 WO
WO-2019161126 August 2019 WO
WO-2019183620 September 2019 WO
WO-2019217478 November 2019 WO
WO-2020008192 January 2020 WO
WO-2020198229 October 2020 WO
WO-2020206085 October 2020 WO
WO-2022221326 October 2022 WO
Other references
  • Co-pending U.S. Appl. No. 29/770,784, inventors Dobak; John et al., filed on Feb. 16, 2021.
  • Co-pending U.S. Appl. No. 29/770,785, inventors Dobak; John et al., filed on Feb. 16, 2021.
  • Co-pending U.S. Appl. No. 29/770,786, inventors Dobak; John et al., filed on Feb. 16, 2021.
  • Co-pending U.S. Appl. No. 29/796,477, inventor Dobak; John, filed on Jun. 24, 2021.
  • Co-pending U.S. Appl. No. 17/933,336, inventors Dubridge; Robert B. et al., filed Sep. 19, 2022.
  • Co-pending U.S. Appl. No. 29/866,396, inventor Makris; Gina, filed Sep. 9, 2022.
  • Co-pending U.S. Appl. No. 29/866,397, inventor Makris; Gina, filed Sep. 9, 2022.
  • Co-pending U.S. Appl. No. 29/866,398, inventor Makris; Gina, filed Sep. 9, 2022.
  • Co-pending U.S. Appl. No. 29/866,399, inventor Makris; Gina, filed Sep. 9, 2022.
  • U.S. Appl. No. 17/195,541 Office Action dated Sep. 28, 2022.
  • Cerda et al. Geometry and Physics of Wrinkling. Phys Rev Lett 90(7):074302 (2003).
  • Childs. Noninvasive gene expression testing in amelanotic melanoma. JAMA Dermatol 154(2):223-224(2018).
  • Co-pending U.S. Appl. No. 29/770,784, inventors Dobak; John et al., filed Feb. 16, 2021.
  • Co-pending U.S. Appl. No. 29/770,785, inventors Dobak; John et al., filed Feb. 16, 2021.
  • Co-pending U.S. Appl. No. 29/770,786, inventors Dobak; John et al., filed Feb. 16, 2021.
  • Co-pending U.S. Appl. No. 29/796,477, inventor Dobak; John, filed Jun. 24, 2021.
  • Dalbe et al. Multiscale Stick-Slip Dynamics of Adhesive Tape Peeling. Phys Rev Lett 115(12):128301 (2015).
  • De Zotti et al. Bending to Kinetic Energy Transfer in Adhesive Peel Front Microinstability. Phys Rev Lett 122(6):068005 (2019).
  • Ferris et al. Impact on clinical practice of a non-invasive gene expression melanoma rule-out test: 12-month follow-up of negative test results and utility data from a large US registry study. Dermatology Online J 25(5):pii (May 2019).
  • Ferris et al. Noninvasive analysis of high-risk driver mutations and gene expression profiles in primary cutaneous melanoma. J Invest Dermatol 139:1127-1134 (2019).
  • Ferris et al. Real-world performance and utility of a noninvasive gene expression assay to evaluate melanoma risk in pigmented lesions. Melanoma Res 28(5):478-482 (2018).
  • Ferris et al. Utility of a noninvasive 2-gene molecular assay for cutaneous melanoma and effect on the decision to biopsy. JAMA Dermatol 153(7):675-680 (2017).
  • Gerami et al. Development and validation of a noninvasive 2-gene molecular assay for cutaneous melanoma. J Am Acad Dermatol 76(1):114-120.e2 (2017).
  • Hornberger et al. Clinical and economic implications of a noninvasive molecular pathology assay for early detection of melanoma. JAMA Dermatol 154(9):1-8 (2018).
  • Instructions for use DermTech adhesive skin biopsy kit. DermTech. Available at http://dermtech.com/wp-content/uploads/2015/10/dermtech-ifu-skin-collection-v7.pdf (Revised data Oct. 2015) (1 pg.).
  • Itoh et al. Generation of 3D skin equivalents fully reconstituted from human induced pluripotent stem cells (iPSCs). PLoS One 8(10):e77673 (2013).
  • Jansen et al. Gene expression analysis differentiates melanomas from Spitz nevi. J Drugs Dermatol 17(5):574-576 (2018).
  • Liu et al. Inhibition of p38 MAPK signaling augments skin tumorigenesis via NOX2 driven ROS generation. PLoS One 9(5):e97245 (2014).
  • Neagu et al. miRNAs in the Diagnosis and Prognosis of Skin Cancer. Front Cell Dev Biol 8:71 (2020).
  • PCT/US2016/30287 International Search Report and Written Opinion dated Aug. 16, 2016.
  • Rivers et al. Non-invasive gene expression testing to rule out melanoma. Skin Therapy Letter 23(5):1-4(2018).
  • Rivers et al. Ruling out Melanoma: A practical guide to improving performance through non-invasive gene expression testing. Skin Therapy Letter: Family Practice Edition 14(1):4-6 (2019).
  • Shen et al., Epigenetic and genetic dissections of UV-induced global gene dysregulation in skin cells through multi-omics analyses. Scientific Reports 7:42646 (2017).
  • Shen et al., Transcriptome analysis identifies the dysregulation of ultraviolet target genes in human skin cancers. PLoS One 11(9):e0163054 [1-14] (2016).
  • Siegel et al. Further consideration of the pigmented lesion assay-reply. JAMA Dermatol 155(3):393-394 (2019).
  • Thoroddsen et al. Stick-slip substructure in rapid tape peeling. Phys Rev Lett 82(4 Pt 2):046107 (2010).
  • Torres et al. MicroRNA Ratios Distinguish Melanomas from Nevi. J Invest Dermatol. 140(1):164-173.e7 (2020).
  • Wachsman et al. Differentiation of melanoma from dysplastic nevi in suspicious pigmented skin lesions by non-invasive tape stripping. Journal of Dermatology 127(Supp 1s):S145 (2007).
  • Yao et al. An adhesive patch-based skin biopsy device for molecular diagnostics and skin microbiome studies. J Drugs Dermatol 16:979-986 (2017).
  • Yao et al. Analytical Characteristics of a Noninvasive Gene Expression Assay for Pigmented Skin Lesions. Assay Drug Del Technol 14(6):355-363 (2016).
Patent History
Patent number: D989861
Type: Grant
Filed: Feb 16, 2021
Date of Patent: Jun 20, 2023
Assignee: DERMTECH, INC. (San Diego, CA)
Inventors: John Daniel Dobak, III (La Jolla, CA), Sarah Dion (San Diego, CA), Burkhard Jansen (La Jolla, CA), Jane Bue (Vista, CA)
Primary Examiner: Abraham Bahta
Application Number: 29/770,783
Classifications